XML 68 R60.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Capital - Disclosure of number and weighted average exercise prices of other equity instruments (Details) | Jun. 30, 2024 shares € / shares | Jun. 10, 2024 share
--- | --- | ---
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | share |  | 106,844
Warrants |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 12,914,414 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 3,239,985 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 3,340,434 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 6,333,995 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 7,084,922 |
BSAAR 2011 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 650,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 25,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 625,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 2.04 |
BSAAR 2012 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 146,050 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 12,250 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 133,800 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 2.04 |
BSAAR 2015 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 1,050,382 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 2,720 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 1,940 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 1,045,722 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 1,045,722 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 7.20 |
AGAP Management 2016-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 2,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 550 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 250 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 1,200 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 156,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Employees 2016-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 2,486 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 251 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 172 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 2,063 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 268,190 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Management 2016-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 50,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 50,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Management 2016-2 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 3,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 3,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 333,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Management 2016-2 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 250,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 250,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Employees 2017-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 5,725 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 5,725 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Management 2017-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 2,400 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 2,400 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Employees 2017 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 114,500 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 4,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 110,500 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Bonus 2018-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 67,028 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 469 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 66,559 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Perf Employees 2018-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 327,500 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 224,375 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 103,125 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Perf Management 2018-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 260,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 150,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 110,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Employees 2018 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 90,650 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 5,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 85,650 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA New Members 2017-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 25,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 25,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Bonus 2019-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 57,376 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 57,376 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Bonus 2020-1 & 2 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 79,861 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 17,885 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 61,976 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Employees 2020-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 766,650 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 681,420 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 85,230 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Management 2020-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 710,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 580,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 130,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Bonus 2021-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 125,748 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 125,748 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Employees 2021-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 1,066,600 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 290,800 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 775,800 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 775,800 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP Management 2021-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 610,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 130,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 480,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 480,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA "Plan Epargne Entreprise" 2022 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 138,960 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 138,960 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Bonus 2022-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 128,061 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 128,061 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Perf Employees 2022-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 1,371,500 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 275,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 1,096,500 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 1,096,500 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Perf Management 2022-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 550,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 550,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 550,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA "Plan Epargne Entreprise" 2023 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 163,293 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 163,293 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA New members 2023-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 25,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 25,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 25,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Perf Employees 2023-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 1,403,500 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 66,250 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 1,337,250 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 1,337,250 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA Perf Management 2023-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 750,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 750,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 750,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA New members 2024-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 25,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 25,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 25,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGA "Plan Epargne Entreprise" 2024 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 68,744 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 68,744 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
Stock Options 2020-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 102,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 102,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP 2019 Employees 2019 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 546,700 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 375,150 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 171,550 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
AGAP 2019 Management 2019 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 355,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 207,500 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 147,500 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 0 |
BSA 2011-2 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 225,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 25,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 200,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 1.77 |
BSA 2013 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 237,500 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 12,500 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 225,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 0 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 2.36 |
BSA 2014 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 150,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 75,000 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 75,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 75,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 8.65 |
BSA 2015-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 70,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 70,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 70,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 9.59 |
BSA 2015-2 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 14,200 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 14,200 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 14,200 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 14.05 |
BSA 2017 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 37,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 37,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 37,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 11.00 |
BSA 2022-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 40,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 31,740 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 8,260 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 8,260 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 2.31 |
BSA 2023-1 |  |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |  |
Number of free shares granted (in shares) | 50,000 |
Number of other equity instruments forfeited in share-based payment arrangement (in shares) | 12,000 |
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | 0 |
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | 38,000 |
Number of other equity instruments exercisable in share-based payment arrangement (in shares) | 38,000 |
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares | € 2.26 |

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSAAR2011Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSAAR2012Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSAAR2015Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPManagement20161Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPEmployees20161Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAManagement20161Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPManagement20162Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAManagement20162Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPEmployees20171Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPManagement20171Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAEmployees2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGABonus20181Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPPerfEmployees20181Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPPerfManagement20181Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAEmployees2018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGANewMembers20171Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGABonus20191Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGABonus202012Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPEmployees20201Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPManagement20201Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGABonus20211Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPEmployees20211Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPManagement20211Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPlanEpargneEntreprise2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGABonus20221Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPerfEmployees20221Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPerfManagement20221Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPlanEpargneEntreprise2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGANewMembers20231Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPerfEmployees20231Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPerfManagement20231Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGANewMembers20241Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAPlanEpargneEntreprise2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_StockOptions20201Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAP2019Employees2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_AGAP2019Management2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA20112Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA2013Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA2014Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA20151Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA20152Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA20221Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=inpha_BSA20231Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |